PS

Pradeep Singh

Active Director Director DIN 09792625
DIN 09792625 First appointment Nov 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Pradeep Singh

Data last updated:

Pradeep Singh is a Director at Fordrx Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Fordrx Pharmaceutical Private Limited reported revenue of ₹4.1 Lakh (FY 2024).

DIN 09792625
Primary Designation Director
Industry Pharma
First Appointment 16 Nov 2022
Oldest Company Age 3 yrs
Largest company Fordrx Pharmaceutical Private Limited · ₹4.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Nov 20222022₹4.1 Lakh (FY 2024)Active

Board colleagues of Pradeep Singh

NameDINCompanyDesignation
Vikrant Singh09792624Fordrx Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fordrx Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Pradeep Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradeep Singh

Pradeep Singh currently holds 1 directorship: Fordrx Pharmaceutical Private Limited (Director, since 16 Nov 2022, revenue ₹4.1 Lakh (FY 2024)).

Pradeep Singh was first appointed on 16 Nov 2022 as Director at Fordrx Pharmaceutical Private Limited.

The current boards of Pradeep Singh's companies include Vikrant Singh (Fordrx Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available